Comparing UroLift Experience Against Rezum (C.L.E.A.R. Study)

Brief description of study

The purpose of this study is to compare two different minimally invasive procedures often used to treat the symptoms of benign prostatic hyperplasia (BPH): the UroLiftTM System procedure and the RezumTM System procedure. Both of these are FDA-approved.

Clinical Study Identifier: s20-01235
Principal Investigator: Jeffrey Todd Schiff.

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.